Cited by 43Cancer Cells and MetastasisMesenchymal stem cell researchMathematical Biology Tumor Growth

Self-Renewal and CSCs In Vitro Enrichment: Growth as Floating Spheres

Open access
Mehta, Pooja, Novak, Caymen, Raghavan, Shreya, Ward, Maria, Mehta, Geeta·2018·Methods in Molecular Biology

Abstract

Cancer stem cells (CSC) are a vital component to the progression and reoccurrence of cancers, making them a primary target of study for both fundamental understanding of cancer biology and the development of effective and targeted treatments. CSCs reside in a complex 3D microenvironment, and the 3D spheroids are an indispensable tool in tumor biology due to their 3D structure and replication of the tumor microenvironment. Within this chapter the methodology for CSC isolation, suspension culture in hanging drop model, and characterization assays for CSC are described. First, the methodology for identifying and isolating CSCs from patient tumors, ascites, or cancer cell lines is described through the use of FACS analysis. Next, a detailed description of 3D hanging drop model for generating CSC spheroids is provided, followed by maintenance and monitoring techniques for extended 3D culture. Analysis methods are described for the quantification of CSC spheroid proliferation and viability tracking, throughout culture by on-plate alamarBlue fluorescence. Additional viability assays are described utilizing confocal microscopy with Live/Dead Viability/Cytotoxicity Kit. The characterization of CSCs populations within spheroids is described through FACS analysis. Further, an immunohistochemistry procedure is described for cell-cell and cell-matrix interaction assessment. Finally, several notes and tips for successful experiments with 3D CSC spheroids on the hanging drop model are provided. These methods are not only applicable to CSCs within a variety of tumor cell types, for not only understanding the fundamental tumor biology, but also for drug screening and development of preclinical chemotherapeutic strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/978-1-4939-7401-6_6

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 22

  1. [1]Magee JA Piskounova E Morrison SJ 2012 Cancer stem cells: impact, heterogeneity, and uncertainty Cancer Cell 21 283 296 22439924 PMC4504432
  2. [2]Wang HJ Guo YQ Tan G 2013 miR-125b regulates side population in breast cancer and confers a chemoresistant phenotype J Cell Biochem 114 2248 2257 23606360
  3. [3]Korkaya H Wicha MS 2010 Cancer stem cells: nature versus nurture Nat Cell Biol 12 419 421 20418873
  4. [4]Wang A Chen L Li C Zhu Y 2015 Heterogeneity in cancer stem cells Cancer Lett 357 63 68 25444897
  5. [5]Hanai JI Doro N Seth P Sukhatme VP 2013 ATP citrate lyase knockdown impacts cancer stem cells in vitro Cell Death Dis 4 e696 23807225 PMC3702307
  6. [6]Singh A Settleman J 2010 EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Oncogene 29 4741 4751 20531305 PMC3176718
  7. [7]Alison MR Lin WR Lim SM Nicholson LJ 2012 Cancer stem cells: in the line of fire Cancer Treat Rev 38 589 598 22469558
  8. [8]Kase M Minajeva A Niinepuu K 2013 Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme Radiol Oncol 47 405 410 24294187 PMC3814287
  9. [9]Longati P Jia X Eimer J 2013 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing BMC Cancer 13 95 23446043 PMC3617005
  10. [10]Raghavan S Mehta P Horst EN Ward MR Rowley KR Mehta G 2016 Comparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicity Oncotarget 7 16948 16961 26918944 PMC4941362
  11. [11]Raghavan S Ward MR Rowley KR 2015 Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays Gynecol Oncol 138 181 189 25913133 PMC4480341
  12. [12]Silva IA Bai S McLean K 2011 Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival Cancer Res 71 3991 4001 21498635 PMC3107359
  13. [13]Futrega K Palmer JS Kinney M 2015 The microwell-mesh: a novel device and protocol for the high throughput manufacturing of cartilage microtissues Biomaterials 62 1 12 26010218
  14. [14]Tung YC Hsiao AY Allen SG Torisawa YS Ho M Takayama S 2011 High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array Analyst 136 473 478 20967331 PMC7454010
  15. [15]Zhou X Holsbeeks I Impens S 2013 Noninvasive real-time monitoring by alamar-Blue((R)) during in vitro culture of three-dimensional tissue-engineered bone constructs Tissue Eng Part C Methods 19 720 729 23327780 PMC3719443
  16. [16]Rampersad SN 2012 Multiple applications of Alamar blue as an indicator of metabolic function and cellular health in cell viability bioas-says Sensors (Basel) 12 12347 12360 23112716 PMC3478843
  17. [17]O’Brien J Wilson I Orton T Pognan F 2000 Investigation of the Alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity Eur J Biochem 267 5421 5426 10951200
  18. [18]Imamura Y Mukohara T Shimono Y 2015 Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer Oncol Rep 33 1837 1843 25634491
  19. [19]Weiswald LB Bellet D Dangles-Marie V 2015 Spherical cancer models in tumor biology Neoplasia 17 1 15 25622895 PMC4309685
  20. [20]Zanoni M Piccinini F Arienti C 2016 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained Sci Rep 6 19103 26752500 PMC4707510
  21. [21]Mehta G Hsiao AY Ingram M Luker GD Takayama S 2012 Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy J Control Release 164 192 204 22613880 PMC3436947
  22. [22]Weiswald LB Guinebretiere JM Richon S Bellet D Saubamea B Dangles-Marie V 2010 In situ protein expression in tumour spheres: development of an immunostaining protocol for confocal microscopy BMC Cancer 10 106 20307308 PMC2851689

Cited by

Sorted by citations

Authors
Mehta, P., Novak, C., Raghavan, S., Ward, M., & Mehta, G.
Affiliations
University of Michigan (US)
Corresponding author
Mehta, Geeta
Venue
Methods in Molecular Biology
Published
2017-10-07
Volume
1692
Pages
61-75
ISSN
  • 1064-3745 (ISSN-L)
  • 1940-6029
OpenAlex
W2761057799
Cited by
43
References
0
Citations by year
2026: 3 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 7 · 2021: 7 · 2020: 9 · 2019: 4 · 2018: 3
FWCI
11.69
Type
book chapter
Language
en
Open access
Locations
  • Methods in molecular biology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Dental and Craniofacial Research (T32DE007057)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
Keywords
cancer stem cells, multicellular spheroids, hanging drop culture, self-renewal, immunohistochemistry, cell-matrix interactions, tumor microenvironment, drug screening
MeSH terms
Cell Survival, Female, Humans, Ovarian Neoplasms, Neoplastic Stem Cells, Spheroids, Cellular, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review